In situ targeting of dendritic cells by antigen-loaded red blood cells: A novel approach to cancer immunotherapy

Vaccine. 2010 Apr 9;28(17):2965-72. doi: 10.1016/j.vaccine.2010.02.013. Epub 2010 Feb 24.

Abstract

Red blood cells (RBCs) were shown to be efficient antigen carriers to target dendritic cells (DCs) and induce cytotoxic T-cell responses. Mouse RBCs were loaded with ovalbumin (RBC-OVA) and injected with Poly (I:C) into mice. Phagocytosis of RBC-OVA by macrophages and DCs was demonstrated to induce OVA-specific CD4(+) and CD8(+) T cell activation. Moreover, these CD8(+) T cells produced IFN-gamma and were able to induce OVA-specific cell lysis. Finally, T-cell response was demonstrated to be dependent on the dose-amount of antigen entrapped and this response could be maintained for up to 30 days.

MeSH terms

  • Animals
  • Antigens, Neoplasm / immunology*
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • Cytotoxicity, Immunologic*
  • Dendritic Cells / immunology*
  • Erythrocytes / immunology*
  • Immunotherapy / methods*
  • Interferon-gamma / metabolism
  • Lymphocyte Activation
  • Macrophages / immunology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neoplasms / therapy*
  • Ovalbumin / immunology
  • Phagocytosis
  • T-Lymphocytes, Cytotoxic / immunology

Substances

  • Antigens, Neoplasm
  • Interferon-gamma
  • Ovalbumin